Publications
5891 Results
- Journal / Conference
- Journal of Clinical Oncology 31(3):373-379
- Year
- 2013
- Research Committee(s)
- Melanoma
- PMID
- PMID23248256
- PMC
- PMC4878104
- Study Number(s)
- CTSU/E2603
Phase III trial of carboplatin and paclitaxel with or without sorafenib in metastatic melanoma
- Journal / Conference
- Journal of Clinical Oncology 31(18):2347-2357
- Year
- 2013
- Research Committee(s)
- Myeloma
- PMID
- PMID23690408
- PMC
- PMC Journal - In process
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease
- Journal / Conference
- Clinical Cancer Research 19(20):5798-5807;
- Year
- 2013
- Research Committee(s)
- Breast
- PMID
- PMID23965903
- PMC
- PMC3805021
- Study Number(s)
- N9831
Impact of c-myc protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (Alliance) N9831
- Journal / Conference
- Cancer 119(15):2675-2682
- Year
- 2013
- Research Committee(s)
- Breast
- PMID
- PMID23744760
- PMC
- PMC4126833
- Study Number(s)
- N9831
Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: results from North Central Cancer Treatment Group adjuvant trial N9831
- Journal / Conference
- Journal of Clinical Oncology 31(17):2115-2122
- Year
- 2013
- Research Committee(s)
- Breast
- PMID
- PMID23650412
- PMC
- PMC3731983
- Study Number(s)
- N9831
Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial
- Journal / Conference
- Cancer 119(16):3007-3011
- Year
- 2013
- Research Committee(s)
- Cancer Control
- PMID
- PMID23720006
- PMC
- PMC3735626
- Study Number(s)
- SWOG-9217
The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcome
- Journal / Conference
- Annals of Surgery 258(3):422-429;
- Year
- 2013
- Research Committee(s)
- Sarcoma
- PMID
- PMID23860199
- PMC
- pending
- Study Number(s)
- CTSU/Z9000
Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor ACOSOG Z9000 (Alliance) intergroup phase 2 trial
- Journal / Conference
- Clinical Colorectal Cancer 12(3):179-187
- Year
- 2013
- Research Committee(s)
- Cancer Survivorship and Gastrointestinal
- PMID
- PMID23810482
- PMC
- PMC3760214
- Study Number(s)
- SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)
The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT database
- Journal / Conference
- Leukemia Research 37(7):795-801
- Year
- 2013
- Research Committee(s)
- Leukemia
- PMID
- PMID23528262
- PMC
- PMC4174301
All-trans retinoic acid and late relapses in acute promyelocytic leukemia: Very long-term follow-up of the North American Intergroup Study I0129
- Journal / Conference
- Current Opinion in Oncology 25(3):242-251
- Year
- 2013
- Research Committee(s)
- Cancer Control, Genitourinary, Prevention, Screening, and and Surveillance
- PMID
- PMID23518594
- PMC
- n/a - review article
- Study Number(s)
- S0000, SWOG-9217, S9917